Advertisement

Citations to this article

Abstract

In broad terms, there are 3 types of cardiac hypertrophy: normal growth, growth induced by physical conditioning (i.e., physiologic hypertrophy), and growth induced by pathologic stimuli. Recent evidence suggests that normal and exercise-induced cardiac growth are regulated in large part by the growth hormone/IGF axis via signaling through the PI3K/Akt pathway. In contrast, pathological or reactive cardiac growth is triggered by autocrine and paracrine neurohormonal factors released during biomechanical stress that signal through the Gq/phospholipase C pathway, leading to an increase in cytosolic calcium and activation of PKC. Here we review recent developments in the area of these cardiotrophic kinases, highlighting the utility of animal models that are helping to identify molecular targets in the human condition.

Authors

Gerald W. Dorn II, Thomas Force

×

Total citations by year in Crossref

Year: 2014 2013 2011 2010 2009 2008 2007 2006 2005 Total
Citations: 9 4 2 1 4 6 12 9 5 52
Citation information

Citations to this article in Crossref (52)

Title and authors Publication Year
Pregnancy as a cardiac stress model
E Chung, LA Leinwand
Cardiovascular Research 2014
Atrial Remodeling and Atrial Fibrillation
S Nattel, M Harada
Journal of the American College of Cardiology 2014
Regulator of G Protein Signaling 3 Protects Against Cardiac Hypertrophy in Mice: RGS3 R EGULATES CARDIAC HYPERTROPHY
Y Liu, H Huang, Y Zhang, XY Zhu, R Zhang, LH Guan, Q Tang, H Jiang, C Huang
Journal of Cellular Biochemistry 2014
Midkine exacerbates pressure overload-induced cardiac remodeling
S Netsu, T Shishido, T Kitahara, Y Honda, A Funayama, T Narumi, S Kadowaki, H Takahashi, T Miyamoto, T Arimoto, S Nishiyama, T Watanabe, CH Woo, Y Takeishi, I Kubota
Biochemical and Biophysical Research Communications 2014
Post-Genomic Cardiology
J Marín-García
Post-Genomic Cardiology 2014
Current Topics in Developmental Biology
LR Fiedler, E Maifoshie, MD Schneider
Current topics in developmental biology 2014
Gαq signalling: The new and the old
G Sánchez-Fernández, S Cabezudo, C García-Hoz, C Benincá, AM Aragay, F Mayor, C Ribas
Cellular Signalling 2014
The eIF2B-interacting domain of RGS2 protects against GPCR agonist-induced hypertrophy in neonatal rat cardiomyocytes
P Chidiac, AJ Sobiesiak, KN Lee, R Gros, CH Nguyen
Cellular Signalling 2014
MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart
KK Baskin, MR Rodriguez, S Kansara, W Chen, S Carranza, OH Frazier, DJ Glass, H Taegtmeyer
Journal of Molecular and Cellular Cardiology 2014
βArrestins in Cardiac G Protein-Coupled Receptor Signaling and Function: Partners in Crime or “Good Cop, Bad Cop”?
A Lymperopoulos, S Negussie
International journal of molecular sciences 2013
Protein kinase C inhibitors: a patent review (2010 – present)
ME Sobhia, BK Grewal, ML Paul, J Patel, A Kaur, T Haokip, A Kokkula
Expert Opinion on Therapeutic Patents 2013
Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats
D Xiao, C Dasgupta, M Chen, K Zhang, J Buchholz, Z Xu, L Zhang
Cardiovascular Research 2013
Growth Hormone Replacement Therapy Prevents Sarcopenia by a Dual Mechanism: Improvement of Protein Balance and of Antioxidant Defenses
T Brioche, RA Kireev, S Cuesta, A Gratas-Delamarche, JA Tresguerres, MC Gomez-Cabrera, J Vina
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2013
Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size
M Xin, Y Kim, LB Sutherland, X Qi, J McAnally, RJ Schwartz, JA Richardson, R Bassel-Duby, EN Olson
Science signaling 2011
Scaffold-Based Transplantation of Akt1 -Overexpressing Skeletal Myoblasts: Functional Regeneration Is Associated with Angiogenesis and Reduced Infarction Size
M Siepe, P Golsong, A Poppe, B Blumenthal, R Wattenwyl, C Heilmann, K Förster, C Schlensak, F Beyersdorf
Tissue Engineering Part A 2011
Cardiology of the Horse
M Bowen
Cardiology of the Horse 2010
CHF1/Hey2 Promotes Physiological Hypertrophy in Response to Pressure Overload through Selective Repression and Activation of Specific Transcriptional Pathways
M Yu, Y Liu, F Xiang, Y Li, D Cullen, R Liao, RP Beyer, TK Bammler, MT Chin
OMICS: A Journal of Integrative Biology 2009
Regulation of phospholipase C in cardiac hypertrophy
PS Tappia, T Singal
Clinical Lipidology 2009
Activated cell survival cascade protects cardiomyocytes from cell death in Tako-Tsubo cardiomyopathy
HM Nef, H Möllmann, P Hilpert, C Troidl, S Voss, A Rolf, CB Behrens, M Weber, CW Hamm, A Elsässer
European Journal of Heart Failure 2009
Selective activation of PI3K /Akt/GSK-3  signalling and cardiac compensatory hypertrophy during recovery from heart failure
JC Braz, RM Gill, AK Corbly, BD Jones, N Jin, CJ Vlahos, Q Wu, W Shen
European Journal of Heart Failure 2009
A broken heart: A stretch too far
L Cox, L Umans, F Cornelis, D Huylebroeck, A Zwijsen
International Journal of Cardiology 2008
Effects of Hawthorn on Cardiac Remodeling and Left Ventricular Dysfunction after 1 Month of Pressure Overload-induced Cardiac Hypertrophy in Rats
HS Hwang, BE Bleske, MM Ghannam, K Converso, MW Russell, JC Hunter, MO Boluyt
Cardiovascular Drugs and Therapy 2008
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
K Lorenz, JP Schmitt, EM Schmitteckert, MJ Lohse
Nature Medicine 2008
Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: role of HIF1  and CREB
J Feng, E Lucchinetti, G Fischer, M Zhu, K Zaugg, MC Schaub, M Zaugg
Cardiovascular Research 2008
Genomics in cardiac metabolism
JL Samuel, MC Schaub, M Zaugg, M Mamas, WB Dunn, B Swynghedauw
Cardiovascular Research 2008

Advertisement
Advertisement